1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Aslan Pharmaceuticals Pte. Ltd. - Product Pipeline Review - 2015

Aslan Pharmaceuticals Pte. Ltd. - Product Pipeline Review - 2015

  • October 2015
  • -
  • Global Markets Direct
  • -
  • 30 pages

Aslan Pharmaceuticals Pte. Ltd. - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘Aslan Pharmaceuticals Pte. Ltd. - Product Pipeline Review - 2015’, provides an overview of the Aslan Pharmaceuticals Pte. Ltd.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Aslan Pharmaceuticals Pte. Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Aslan Pharmaceuticals Pte. Ltd. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Aslan Pharmaceuticals Pte. Ltd.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Aslan Pharmaceuticals Pte. Ltd.’s pipeline products

Reasons to buy

- Evaluate Aslan Pharmaceuticals Pte. Ltd.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Aslan Pharmaceuticals Pte. Ltd. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Aslan Pharmaceuticals Pte. Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Aslan Pharmaceuticals Pte. Ltd. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Aslan Pharmaceuticals Pte. Ltd.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
- Explore the dormant and discontinued projects of Aslan Pharmaceuticals Pte. Ltd. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

Table Of Contents

Aslan Pharmaceuticals Pte. Ltd. - Product Pipeline Review - 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Aslan Pharmaceuticals Pte. Ltd. Snapshot 5
Aslan Pharmaceuticals Pte. Ltd. Overview 5
Key Information 5
Key Facts 5
Aslan Pharmaceuticals Pte. Ltd. - Research and Development Overview 6
Key Therapeutic Areas 6
Aslan Pharmaceuticals Pte. Ltd. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Partnered Products 10
Partnered Products/Combination Treatment Modalities 11
Aslan Pharmaceuticals Pte. Ltd. - Pipeline Products Glance 12
Aslan Pharmaceuticals Pte. Ltd. - Clinical Stage Pipeline Products 12
Phase II Products/Combination Treatment Modalities 12
Phase I Products/Combination Treatment Modalities 13
Aslan Pharmaceuticals Pte. Ltd. - Early Stage Pipeline Products 14
Preclinical Products/Combination Treatment Modalities 14
Aslan Pharmaceuticals Pte. Ltd. - Drug Profiles 15
varlitinib 15
Product Description 15
Mechanism of Action 15
RandD Progress 15
ASLAN-003 18
Product Description 18
Mechanism of Action 18
RandD Progress 18
BMS-777607 19
Product Description 19
Mechanism of Action 19
RandD Progress 19
ASLAN-004 20
Product Description 20
Mechanism of Action 20
RandD Progress 20
Aslan Pharmaceuticals Pte. Ltd. - Pipeline Analysis 21
Aslan Pharmaceuticals Pte. Ltd. - Pipeline Products by Target 21
Aslan Pharmaceuticals Pte. Ltd. - Pipeline Products by Route of Administration 22
Aslan Pharmaceuticals Pte. Ltd. - Pipeline Products by Molecule Type 23
Aslan Pharmaceuticals Pte. Ltd. - Pipeline Products by Mechanism of Action 24
Aslan Pharmaceuticals Pte. Ltd. - Recent Pipeline Updates 25
Aslan Pharmaceuticals Pte. Ltd. - Dormant Projects 27
Aslan Pharmaceuticals Pte. Ltd. - Locations And Subsidiaries 28
Head Office 28
Other Locations and Subsidiaries 28
Appendix 29
Methodology 29
Coverage 29
Secondary Research 29
Primary Research 29
Expert Panel Validation 29
Contact Us 29
Disclaimer 30

List of Tables
Aslan Pharmaceuticals Pte. Ltd., Key Information 5
Aslan Pharmaceuticals Pte. Ltd., Key Facts 5
Aslan Pharmaceuticals Pte. Ltd. - Pipeline by Indication, 2015 7
Aslan Pharmaceuticals Pte. Ltd. - Pipeline by Stage of Development, 2015 8
Aslan Pharmaceuticals Pte. Ltd. - Monotherapy Products in Pipeline, 2015 9
Aslan Pharmaceuticals Pte. Ltd. - Partnered Products in Pipeline, 2015 10
Aslan Pharmaceuticals Pte. Ltd. - Partnered Products/ Combination Treatment Modalities, 2015 11
Aslan Pharmaceuticals Pte. Ltd. - Phase II, 2015 12
Aslan Pharmaceuticals Pte. Ltd. - Phase I, 2015 13
Aslan Pharmaceuticals Pte. Ltd. - Preclinical, 2015 14
Aslan Pharmaceuticals Pte. Ltd. - Pipeline by Target, 2015 21
Aslan Pharmaceuticals Pte. Ltd. - Pipeline by Route of Administration, 2015 22
Aslan Pharmaceuticals Pte. Ltd. - Pipeline by Molecule Type, 2015 23
Aslan Pharmaceuticals Pte. Ltd. - Pipeline Products by Mechanism of Action, 2015 24
Aslan Pharmaceuticals Pte. Ltd. - Recent Pipeline Updates, 2015 25
Aslan Pharmaceuticals Pte. Ltd. - Dormant Developmental Projects,2015 27
Aslan Pharmaceuticals Pte. Ltd., Other Locations 28

List of Figures
Aslan Pharmaceuticals Pte. Ltd. - Pipeline by Top 10 Indication, 2015 7
Aslan Pharmaceuticals Pte. Ltd. - Pipeline by Stage of Development, 2015 8
Aslan Pharmaceuticals Pte. Ltd. - Monotherapy Products in Pipeline, 2015 9
Aslan Pharmaceuticals Pte. Ltd. - Pipeline by Top 10 Target, 2015 21
Aslan Pharmaceuticals Pte. Ltd. - Pipeline by Top 10 Route of Administration, 2015 22
Aslan Pharmaceuticals Pte. Ltd. - Pipeline by Top 10 Molecule Type, 2015 23
Aslan Pharmaceuticals Pte. Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2015 24

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
cAMP and cAMP Inhibited cGMP 3%,5% Cyclic Phosphodiesterase 10A (Phosphodiesterase 10A1 or Phosphodiesterase 10A7 or PDE10A or EC 3.1.4.17 or EC 3.1.4.35) - Pipeline Review, H2 2016

cAMP and cAMP Inhibited cGMP 3%,5% Cyclic Phosphodiesterase 10A (Phosphodiesterase 10A1 or Phosphodiesterase 10A7 or PDE10A or EC 3.1.4.17 or EC 3.1.4.35) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

cAMP and cAMP Inhibited cGMP 3',5' Cyclic Phosphodiesterase 10A (Phosphodiesterase 10A1 or Phosphodiesterase 10A7 or PDE10A or EC 3.1.4.17 or EC 3.1.4.35) - Pipeline Review, H2 2016 Summary Global Markets ...

Iduronate 2 Sulfatase (Alpha L Iduronate Sulfate Sulfatase or Idursulfase or IDS or EC 3.1.6.13) - Pipeline Review, H2 2016

Iduronate 2 Sulfatase (Alpha L Iduronate Sulfate Sulfatase or Idursulfase or IDS or EC 3.1.6.13) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Iduronate 2 Sulfatase (Alpha L Iduronate Sulfate Sulfatase or Idursulfase or IDS or EC 3.1.6.13) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Iduronate 2 Sulfatase (Alpha L Iduronate ...

Potassium Voltage Gated Channel Subfamily KQT Member 3 (Potassium Channel Subunit Alpha KvLQT3 or Voltage Gated Potassium Channel Subunit Kv7.3 or KCNQ3) - Pipeline Review, H2 2016

Potassium Voltage Gated Channel Subfamily KQT Member 3 (Potassium Channel Subunit Alpha KvLQT3 or Voltage Gated Potassium Channel Subunit Kv7.3 or KCNQ3) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Potassium Voltage Gated Channel Subfamily KQT Member 3 (Potassium Channel Subunit Alpha KvLQT3 or Voltage Gated Potassium Channel Subunit Kv7.3 or KCNQ3) - Pipeline Review, H2 2016 Summary Global Markets ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.